0001104659-23-109607.txt : 20231017 0001104659-23-109607.hdr.sgml : 20231017 20231017160513 ACCESSION NUMBER: 0001104659-23-109607 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231017 DATE AS OF CHANGE: 20231017 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CAPRICOR THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001133869 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-81959 FILM NUMBER: 231329646 BUSINESS ADDRESS: STREET 1: 8840 WILSHIRE BLVD STREET 2: 2ND FLOOR CITY: BEVERLY HILLS STATE: CA ZIP: 90211 BUSINESS PHONE: (310) 358-3200 MAIL ADDRESS: STREET 1: 8840 WILSHIRE BLVD STREET 2: 2ND FLOOR CITY: BEVERLY HILLS STATE: CA ZIP: 90211 FORMER COMPANY: FORMER CONFORMED NAME: Nile Therapeutics, Inc. DATE OF NAME CHANGE: 20070920 FORMER COMPANY: FORMER CONFORMED NAME: SMI PRODUCTS INC DATE OF NAME CHANGE: 20010206 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Nippon Shinyaku Co Ltd CENTRAL INDEX KEY: 0001361865 IRS NUMBER: 000000000 STATE OF INCORPORATION: M0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 14 NISHINOSHO MONGUCHI CHO STREET 2: KISSHOIN MINAMIKU CITY: KYOTO STATE: M0 ZIP: 00000 BUSINESS PHONE: 81 75 321 9104 MAIL ADDRESS: STREET 1: 14 NISHINOSHO MONGUCHI CHO STREET 2: KISSHOIN MINAMIKU CITY: KYOTO STATE: M0 ZIP: 00000 SC 13G 1 tm2328179d1_sc13g.htm SC 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 13G

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No.     )*

 
Capricor Therapeutics, Inc.
(Name of Issuer)

 

Common Stock
(Title of Class of Securities)
 
14070B309
(CUSIP Number)

 

October 3, 2023
(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  ¨ Rule 13d-1(b)
     
  x Rule 13d-1(c)
     
  ¨ Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

CUSIP No. 14070B309 13G Page 1 of 5 Pages

(l)

Names of Reporting Persons.

 

Nippon Shinyaku Co., Ltd.

(2)

Check the Appropriate Box if a Member of a Group

 

(a) ¨

(b) ¨

(3)

SEC Use Only

 

 

(4)

Citizenship or Place of Organization

 

Japan

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person With

(5)

Sole Voting Power

 

2,145,922

(6)

Shared Voting Power

 

0

(7)

Sole Dispositive Power

 

2,145,922

(8)

Shared Dispositive Power

 

0

(9)

Aggregate Amount Beneficially Owned by Each Reporting Person

 

2,145,922

(10)

Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

(11)

Percent of Class Represented by Amount in Row (9)

 

6.97%*

(12)

Type of Reporting Person

 

FI

 

* Calculated based on 30,790,691 shares outstanding of the Issuer.

 

 

 

 

Item l(a). Name of Issuer:

 

Capricor Therapeutics, Inc.

 

Item l(b). Address of Issuer’s Principal Executive Offices:

 

840 Wilshire Blvd., 2nd Floor, Beverly Hills, California 90211

 

Item 2(a). Name of Person Filing:

 

Nippon Shinyaku Co., Ltd.

 

Item 2(b). Principal Business Offices or, if None, Residence:

 

14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku,

Kyoto 601-8550, Japan

 

Item 2(c). Citizenship:

 

The Reporting Person is organized under the laws of Japan.

 

Item 2(d). Title of Class of Securities:

 

Common Stock, par value $0.001

 

Item 2(e). CUSIP Number:

 

14070B309

 

Item 3. If this statement is filed pursuant to 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

 

(b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

 

(c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

 

(d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);

 

(e) ¨ An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);

 

(f) ¨ An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);

 

(g) ¨ A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);

 

(h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

(i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

 

(j) ¨ a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);

 

(k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K),

 

 

 

 

Item 4. Ownership.

 

(a) Amount beneficially owned:
   
  2,145,922
   
(b) Percent of class:
   
  6.97%*
   
(c) Number of shares as to which such person has:
   
(i) Sole power to vote or to direct the vote:
   
  2,145,922
   
(ii) Shared power to vote or to direct the vote:
   
  -
   
(iii) Sole power to dispose or to direct the disposition of:
   
  2,145,922
   
(iv) Shared power to dispose or to direct the disposition of:
   
  -

 

5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ¨.

 

6. Ownership of More than Five Percent on Behalf of Another Person.

 

Not Applicable

 

7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.

 

N/A

 

8. Identification and Classification of Members of the Group.

 

N/A

 

9. Notice of Dissolution of Group.

 

N/A

 

10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

 

* Calculated based on 30,790,691 shares outstanding of the Issuer.

 

 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  Date: October 17, 2023
   
  By: /s/ Takanori Edamitsu
   
  Name and Title: Takanori Edamitsu, Director, Business Management & Sustainability